Psoriasis

The Pharmacy Times® Psoriasis Resource Center is a comprehensive resource for clinical news and expert insights on treatments for psoriasis.

Latest News

Man scratch oneself, dry flaky skin on hand with psoriasis vulgaris, eczema and other skin conditions like fungus, plaque, rash and patches. Autoimmune genetic disease - Image credit: Ольга Тернавская | stock.adobe.com
Ustekinumab Biosimilar Launches in the US

March 20th 2025

The launch of ustekinumab-stba following its FDA approval expands patient access to this therapy with a variety of indications.

Psoriasis skin. Closeup of rash and scaling on the patient's skin. The concept of chronic disease treatment. Dermatological problems. Hard, horny and cracked skin in woman's hands.
Icotrokinra Demonstrates Meaningful Skin Clearance in Moderate-to-Severe Plaque Psoriasis

March 10th 2025

Doctor dermatologist examines skin of patient. Dermatoscopy, prevention of melanoma, skin cancer - Image credit: InsideCreativeHouse | stock.adobe.com
Pharmacists Can Improve Specialty Medication Management in Dermatology

February 19th 2025

Patient with psoriasis, psoriatic arthritis -- Image credit: Ольга Тернавская | stock.adobe.com
Pharmacists Play a Crucial Role Monitoring Patients With Psoriasis and Psoriatic Arthritis

February 14th 2025

fda approved label. fda approved red band sign. fda approved - Image credit: Aquir | stock.adobe.com
Ustekinumab-stba Receives FDA Approval for Autoimmune Disorder and Inflammatory Bowel Disease

December 18th 2024

Latest CME Events & Activities

The Role of Daily Photoprotection and Antioxidants in Sun Protection: A Guide for Pharmacists and Pharmacy Tec...

1.0 Credit / Dermatology, OTC

View More

Understanding the Role of Ceramides in Acne Management: Opportunities to Improve Clinical Outcomes (Pharmacy T...

1.0 Credit / Dermatology, OTC

View More

Skin-Related Changes in Persons With Diabetes: Using Ceramides to Address Skin Barrier Dysfunction (Pharmacy T...

1.0 Credit / Dermatology, OTC

View More

Adjunctive Therapies in Atopic Dermatitis: Understanding the Role of the Skin Barrier and Microbiome in Diseas...

1.0 Credit / Dermatology, OTC

View More

Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction (Pharmacy Technici...

0.75 Credit / Dermatology, OTC

View More

Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Ca...

0.5 Credit / Dermatology, OTC

View More

Addressing the Challenges of Treating Moderate to Severe Atopic Dermatitis With Targeted Biologic Therapies in...

1.5 Credits / Allergy, Dermatology, Immunology

View More

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology

View More

Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care

1.5 Credits / Dermatology

View More

Alleviating Patient Burden in Acne: Utilizing Ceramides to Address Skin Barrier Dysfunction

0.75 Credit / Dermatology, OTC

View More

Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Ca...

0.5 Credit / Dermatology, OTC

View More

Skin-Related Changes in Persons With Diabetes: Using Ceramides to Address Skin Barrier Dysfunction

1.0 Credit / Dermatology, OTC

View More

Adjunctive Therapies in Atopic Dermatitis: Understanding the Role of the Skin Barrier and Microbiome in Diseas...

1.0 Credit / Dermatology, OTC

View More

Understanding the Role of Ceramides in Acne Management: Opportunities to Improve Clinical Outcomes

1.0 Credit / Dermatology, OTC

View More

The Role of Daily Photoprotection and Antioxidants in Sun Protection: A Guide for Pharmacists and Pharmacy Tec...

1.0 Credit / Dermatology, OTC

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

Balancing the Burden of Moderate to Severe Atopic Dermatitis in Pediatric Patients: Navigating the Use of Targ...

1.5 Credits / Dermatology, Immunology

View More

More News

Clinical Overview: Cyletzo, a Biosimilar Version of Adalimumab

Clinical Overview: Cyletzo, a Biosimilar Version of Adalimumab

Ryan Kurschner
July 19th 2022

Indications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Read More

Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque Psoriasis

Clinical Overview: Tildrakizumab-asmn (Ilumya) for Plaque Psoriasis

Marlene Wang, MS
July 18th 2022

Tildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.

Read More

Bristol Myers Squibb Reports Positive Data on Deucravacitinib for Plaque Psoriasis

Bristol Myers Squibb Reports Positive Data on Deucravacitinib for Plaque Psoriasis

Ashley Gallagher, Editor
May 13th 2022

Long-term extension trial results show a consistent safety profile and durable efficacy for the treatment of adults with the skin condition.

Read More

Study: Corticosteroids May Increase Risk of Herpes Zoster for Individuals With Psoriasis

Study: Corticosteroids May Increase Risk of Herpes Zoster for Individuals With Psoriasis

Ashley Gallagher, Editor
May 11th 2022

The results of a network analyses show that the elevated potential of contracting the virus is also linked to infliximab and tofacitinib, as well as several combination treatments.

Read More

Biosimilar Candidate to Ustekinumab Shows Positive Results Treating Plaque Psoriasis

Biosimilar Candidate to Ustekinumab Shows Positive Results Treating Plaque Psoriasis

Jill Murphy, Associate Editor
April 20th 2022

The phase 3, multicenter, randomized, double-blinded, comparative clinical study was evaluating the efficacy and safety of ABP 654 compared with ustekinumab in adult patients with moderate to severe plaque psoriasis.

Read More

Clinical Overview: Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis

Clinical Overview: Deucravacitinib for the Treatment of Moderate to Severe Plaque Psoriasis

Christina Nault
March 31st 2022

Deucravacitinib is a possible solution for patients with psoriasis who wish to have the convenience of an oral medication.

Read More

Psoriasis Drug Guselkumab Shows Durable Skin Clearance Through 5 Years for Adults

Psoriasis Drug Guselkumab Shows Durable Skin Clearance Through 5 Years for Adults

Caitlin Mollison
March 28th 2022

Johnson & Johnson’s Janssen Pharmaceutical Companies subsidiary’s post-hoc analysis of Tremfya demonstrates clinically significant improvements.

Read More

Apremilast Shows Statistically Significant Improvements in Genital Psoriasis

Apremilast Shows Statistically Significant Improvements in Genital Psoriasis

Aislinn Antrim, Managing Editor
January 18th 2022

Oral apremilast achieved a clinically meaningful and statistically significant improvement in the primary endpoint of the modified static Physician’s Global Assessment of Genitalia response.

Read More

FDA Approves Apremilast for Plaque Psoriasis, Regardless of Severity Level

FDA Approves Apremilast for Plaque Psoriasis, Regardless of Severity Level

Alana Hippensteele, Lead Editor
December 22nd 2021

The drug is the first and only oral therapy approved for the treatment of adult patients who are candidates for either phototherapy or systemic therapy.

Read More

Study: Severe Asthma Symptoms Worsen When Treated With Psoriasis Medicine

Study: Severe Asthma Symptoms Worsen When Treated With Psoriasis Medicine

Jill Murphy, Associate Editor
November 15th 2021

The study enrolled 214 patients, with 105 randomized to a risankizumab injection every 4 weeks over a 24-week period, while 109 patients received a placebo.

Read More

Individuals With Psoriasis Are Hesitant to Get Vaccinated for COVID-19

Individuals With Psoriasis Are Hesitant to Get Vaccinated for COVID-19

Ashley Gallagher, Editor
October 1st 2021

The main factors behind the vaccine hesitancy are the potential adverse effects post-vaccination and effect on their autoimmune conditions, as well as lack of trial data, an analysis shows.

Read More

<123